Imatinib mesylate 220127-57-1 99%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2024-02-24
Product Details
- Product NameImatinib mesylate
- CAS No.220127-57-1
- EINECS No.606-892-3
- MFC30H35N7O4S
- MW589.71
- AppearanceWhite solidwhite to beige
- Melting point 214-224°C
- storage temp. 2-8°C
Company Profile Introduction
Headquartered in Chandigarh, India, Ind-Swift Laboratories Ltd. today is a global manufacturer of APIs, Intermediates, and formulations (through group collaboration). With regulated 6+ manufacturing sites (including 2 group subsidiaries) in Punjab and Jammu, we cater to the API needs of regulated markets including USFDA, EDQM, PMDA, ANVISA, EU-GMP, KFDA, NMO, ANSM, Cofepris, TGA, WHO, ROW.
Today, Ind-Swift Laboratories Ltd. is a significant player in manufacturing APIs towards Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Antimigraine, Parkinson’s Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence and Bone Resorption Inhibitor. We also hold global leadership positions in the Macrolide Antibiotic segment
Our organization’s manufacturing facilities are enabled with state-of-art infrastructure, that enables us to comply with our global aspirations. On grounds of consistent regulatory approvals, our products are today being supplied across the globe.
Today, Ind-Swift Laboratories Ltd. is a significant player in manufacturing APIs towards Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Antimigraine, Parkinson’s Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence and Bone Resorption Inhibitor. We also hold global leadership positions in the Macrolide Antibiotic segment
Our organization’s manufacturing facilities are enabled with state-of-art infrastructure, that enables us to comply with our global aspirations. On grounds of consistent regulatory approvals, our products are today being supplied across the globe.
Supplier other products
Recommended supplier
-
VIP1年
- AKASH PHARMA EXPORTS
- Imatinib Mesylate 99%
- Inquiry
- 2024-05-16
-
VIP1年
- Akums Lifesciences Ltd
- Imatinib mesylate 220127-57-1 99%
- Inquiry
- 2024-03-29
-
VIP1年
- Kekule Life Sciences Limited
- Imatinib mesylate 99%
- Inquiry
- 2024-03-19
-
VIP1年
- Aspen Biopharma Labs Pvt Ltd
- 220127-57-1 98%
- Inquiry
- 2024-03-16
-
VIP1年
- Ratnagene lifescience Pvt Ltd
- Imatinib mesylate 220127-57-1 98%
- Inquiry
- 2024-03-16
-
VIP1年
- Fresenius Kabi Oncology Limited
- 220127-57-1 Imatinib mesylate 98%
- Inquiry
- 2024-03-14
-
VIP1年
- Myosynth Laboratories Pvt Ltd
- Imatinib mesylate 220127-57-1 98%
- Inquiry
- 2024-03-14
-
VIP1年
- SP Accure Labs Pvt Ltd (SPAL)
- 220127-57-1 Imatinib mesylate 98%
- Inquiry
- 2024-03-13
-
VIP1年
- Khandelwal Laboratories Private Limited
- Imatinib mesylate 220127-57-1 98%
- Inquiry
- 2024-03-06
-
VIP1年
- Mac Chem Products (India) Pvt Ltd (Naprod Group)
- 220127-57-1 98%
- Inquiry
- 2024-02-28
- Since:2020-02-01
- Address: 711-712, Modi Tower, 98 Nehru Place, New Delhi-160101, India.
INQUIRY